sci天天读
癌症类器官2.0:肿瘤免疫微环境复杂性建模
SCI30 July 2024Cancer organoids 2.0: modelling the complexit...
美国人口中因种族/民族和社会人口因素导致的空气污染死亡率的差异
SCI29 July 2024Disparities in air pollution attributable mor...
在ALK融合阳性NSCLC中ALK酪氨酸激酶抑制剂一线治疗期间EML4-ALK变异和伴随发生TP53突变的影响和总体生存率的研究
SCI28 July 2024Impact of EML4-ALK variants and co-occurring...
循环肿瘤DNA分析可预测短程巩固免疫疗法在不可切除III期非小细胞肺癌中的结局
SCI27 July 2024Analysis of Circulating Tumor DNA Predicts Ou...
双联化疗、三联化疗或双联化疗联合放疗作为局部晚期食管癌的新辅助治疗：一项随机对照、开放标签的 3 期试验
SCI26 July 2024Doublet chemotherapy， triplet chemotherapy
2000-2009年按癌症类型、性别、世界卫生组织地区和世界银行收入水平分列的183个国家的过早死亡的趋势报道
SCI25 July 2024Premature mortality trends in 183 countries by cancer type， sex
早期非小细胞肺癌术前ctDNA检测的临床应用
SCI24 July 2024Clinical Utility of Tumor-Naïve Pre-surgical ctDNA Detection in Early-stage NSCLC
2013-23年英格兰成年人长期使用电子烟的趋势：基于人群的研究
SCI23 July 2024Trends in long term vaping among adults in England, 2013-23: population based study
治疗期间检测EGFR突变阳性晚期非小细胞肺癌进展的ctDNA 纵向分析：来自FLAURA和AURA3的数据
SCI22 July 2024Longitudinal Analyses of Circulating-Tumor DNA for Detection of EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Progression During Treatment: Data From FLAURA and AURA3
STING信号的平衡协调了癌症中的免疫反应
SCI21 July 2024The balance of STING signaling orchestrates immunity in cancer
3D纤维结构在癌症中的重要性和对生物材料模型设计的影响
SCI20 July 2024The importance of 3D fibre architecture in cancer and implications for biomaterial model design
基因组加倍肿瘤中染色体不稳定性的历史
SCI19 July 2024The history of chromosomal instability in genome doubled tumors
BRCA1介导的铁死亡的双重调控揭示了BRCA1缺陷型癌症中GPX4和PARP联合抑制的脆弱性
SCI18 July 2024BRCA1-mediated dual regulation of ferr optosisexposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers
肥胖诱导巨噬细胞PD-1抑制抗肿瘤免疫
SCI17 July 2024Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
HRS-4642在KRAS G12D突变癌症中的抗肿瘤作用及其与蛋白酶体抑制的潜在组合
SCI16 July 2024Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
新辅助SHR-1701有无联合化疗治疗不可切除的III期非小细胞肺癌
SCI15 July 2024Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small cell lung cancer: A proof-of-concept, phase 2 trial
打断肿瘤内CD8+ T: Treg串扰可改善PD-1免疫疗法的疗效
SCI14 July 2024Interruption of the intratumor CD8+ T cell: Treg crosstalk improves the efficacy of PD-1 immunotherapy
皮下注射与静脉注射Amivantamab与Lazertinib联合治疗难治性EGFR突变NSCLC:3期PAOMA-3研究结果
SCI13 July 2024Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR-mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study
用[89Zr]Zr-DFO-SC16.56抗DLL3抗体对肺部和前列腺高级别神经内分泌肿瘤患者进行成像：一项1/2期首次人体试验
SCI12 July 2024Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
早期可切除非小细胞肺癌(NSCLC)的新辅助和辅助治疗:国际肺癌研究协会(IASLC)的共识建议
SCI11 July 2024Neoadjuvant and Adjuvant Treatment for Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): Consensus Recommendations from the International Association for the Study of Lung Cancer (IASLC)